mitomycin has been researched along with Experimental Pneumococcal Meningitis in 1 studies
Mitomycin: An antineoplastic antibiotic produced by Streptomyces caespitosus. It is one of the bi- or tri-functional ALKYLATING AGENTS causing cross-linking of DNA and inhibition of DNA synthesis.
mitomycin : A family of aziridine-containing natural products isolated from Streptomyces caespitosus or Streptomyces lavendulae.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cabellos, C | 1 |
| Guillem, L | 1 |
| Pelegrin, I | 1 |
| Tubau, F | 1 |
| Ardanuy, C | 1 |
| Gudiol, F | 1 |
| Ariza, J | 1 |
| Viladrich, PF | 1 |
1 other study available for mitomycin and Experimental Pneumococcal Meningitis
| Article | Year |
|---|---|
Penicillin- and Cephalosporin-Resistant Pneumococcal Meningitis: Treatment in the Real World and in Guidelines.
Topics: Anti-Bacterial Agents; Cefotaxime; Ceftriaxone; Cephalosporins; Cohort Studies; Humans; Meningitis, | 2022 |